Thirdly, there are still some other confounding factors that may affect plasma SDF-1 levels or NAFLD, such as race, genetic heterogeneity, puberty, dietary patterns or physical activity. The gene discussed is CXCL12; the disease is metabolic dysfunction-associated steatotic liver disease.